Azithromycin

Adult Patients ( ) Infection Recommended Dose/Duration of Therapy Community-acquired pneumonia (mild severity) Pharyngitis/tonsillitis (second-line therapy) Skin/skin structure (uncomplicated) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5 or 500 mg once daily for 3 days. Acute bacterial sinusitis 500 mg once daily for 3 days.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Patients with known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide drug. (), Patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin. () 4.1 Hypersensitivity Azithromycin tablets are contraindicated in patients with known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide drug. 4.2 Hepatic Dysfunction Azithromycin tablets are contraindicated in patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Serious (including fatal) allergic and skin reactions: Discontinue azithromycin if reaction occurs. (), Hepatotoxicity: Severe, and sometimes fatal, hepatotoxicity has been reported. Discontinue azithromycin immediately if signs and symptoms of hepatitis occur. (), Infantile Hypertrophic Pyloric Stenosis (IHPS): Following the use of azithromycin in neonates (treatment up to 42 days of life), IHPS has been reported. Direct parents and caregivers to contact their physician if vomiting or irritability with feeding occurs. (), Prolongation of QT interval and cases of torsades de pointes have been reported.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following clinically significant adverse reactions are described elsewhere in labeling: Hypersensitivity, Hepatotoxicity, Infantile Hypertrophic Pyloric Stenosis (IHPS), QT Prolongation, Cardiovascular Death, Clostridioides difficile- Associated Diarrhea (CDAD), Exacerbation of Myasthenia Gravis Most common adverse reactions are diarrhea (5 to 14%), nausea (3 to 18%), abdominal pain (3 to 7%), or vomiting (2 to 7%).

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

4571 products from 2074 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 4571 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Stored at 20° to 25°C (68° to 77°F).

Storage information from the U.S. FDA-approved label.